Dr. Li is responsible for the overall management, business strategies, regulatory approvals and commercial suitability and sustainability of products of the Group. Dr. Li has over 19 years of experience in the biopharmaceutical industry, and he was the former engineer in charge of the research and development department in Genentech, a former senior scientist in Amgen and a former engineer at Tanox.
Mr. Liang is responsible for clinical development, operation and management. Mr.Liang has over 13 years of experience in clinical development in China and the United States with strong expertise in medical sciences and biostatistics. He was a former vice president and the general manager for ICON Greater China, a former vice president and the general manager for WuXi Clinical, and a former senior director and general manager for Quintiles Dalian Center of Excellence.
Dr. Liu is responsible for pharmacology, translational medicine and regulatory affairs. Dr. Liu has over 20 years of experience in the biopharmaceutical industry, and she was a former scientist and senior scientist at Gilead Sciences, Genentech and Tanox.
Dr. Li is responsible for the preliminary research and development of Innovation Technology Platform. Dr. Li has over 13 years of experience in the biopharmaceutical industry. She was a former associate professor for National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences and a former associate professor for Shanghai Institute for Advanced Immunochemical Studies (SIAIS), ShanghaiTech University.
Chairman of the Board and General Manager
Chief Medical Officer and Deputy General Manager
Deputy General Manager
(Translational Medicine and Regulatory Affairs)
Deputy General Manager
(Innovation Technology Platform)
